Glutamate modulation by evenamide, a Na+ channel blocker, may benefit treatment resistant schizophrenic (TRS) patients not responding to clozapine
In: European Neuropsychopharmacology, Jg. 29 (2019), S. S540- (2S.)
Online
unknown
Zugriff:
Titel: |
Glutamate modulation by evenamide, a Na+ channel blocker, may benefit treatment resistant schizophrenic (TRS) patients not responding to clozapine
|
---|---|
Autor/in / Beteiligte Person: | Bortolato, Marco ; Anand, Ravi ; Faravelli, L. |
Link: | |
Zeitschrift: | European Neuropsychopharmacology, Jg. 29 (2019), S. S540- (2S.) |
Veröffentlichung: | Elsevier BV, 2019 |
Medientyp: | unknown |
ISSN: | 0924-977X (print) |
DOI: | 10.1016/j.euroneuro.2018.11.799 |
Schlagwort: |
|
Sonstiges: |
|